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Abstract The country of Fiji, with a population of approximately 870 000 people, faces a growing burden of
several communicable diseases including the bacterial infection typhoid fever. Surveillance data
suggest that typhoid has become increasingly common in rural areas of Fiji and is more frequent
amongst young adults. Transmission of the organisms that cause typhoid is facilitated by faecal
contamination of food or water and may be influenced by local behavioural practices in Fiji. The
Fijian Ministry of Health, with support from Australian Aid, hosted a meeting in August 2012 to
develop comprehensive control and prevention strategies for typhoid fever in Fiji. International and
local specialists were invited to share relevant data and discuss typhoid control options. The resultant
recommendations focused on generating a clearer sense of the epidemiology of typhoid in Fiji and
exploring the contribution of potential transmission pathways. Additionally, the panel suggested steps
such as ensuring that recommended ciprofloxacin doses are appropriate to reduce the potential for
relapse and reinfection in clinical cases, encouraging proper hand hygiene of food and drink handlers,
working with water and sanitation agencies to review current sanitation practices and considering a
vaccination policy targeting epidemiologically relevant populations.
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Introduction
Enteric fever is a systemic, human-restricted infection
caused predominantly by Salmonella enterica serovars
typhi (S. typhi) and Paratyphi A (S. paratyphi A), result-
ing in typhoid and paratyphoid fevers, respectively (Parry
et al. 2002; Basnyat 2005). Transmitted faecal orally
through contaminated food or water, typhoid is generally
associated with poor sanitation and hygiene (Swaddiwu-
dhipong & Kanlayanaphotporn 2001; Kothari et al.
2008). Bacteraemia presents after 1–2 weeks, causing a
persistent fever with malaise and can result in protracted
illness lasting several weeks. Although rarely fatal with
appropriate antimicrobial treatment, untreated typhoid
can lead to life-threatening complications including hypo-
tensive shock and intestinal perforation (Parry et al.
2002; Chanh et al. 2004).
The Republic of Fiji is a country in the South Pacific
with a population of approximately 870 000 people (UN
2011). The country comprises >300 islands with a total
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land area of 18 000 km2 (FMOH 2011). In addition to the
challenge of providing adequate health services to a dis-
persed population, Fiji is faced with a substantial burden
of communicable and non-communicable diseases as it
undergoes an economic transition to an upper-middle
income country (Australian Aid 2010; FMOH 2011). The
Fijian Ministry of Health (MOH) has expressed particular
concern over the rapid rise in reported cases of typhoid
and leptospirosis, which along with dengue fever, are cur-
rently referred to locally as the ‘three plagues’ (FMOH
2010a, 2011a; WHO/FMOH/UNDP 2011). Improved sur-
veillance and a series of recent typhoid outbreaks have
increased typhoid awareness amongst both medical profes-
sionals and the general public (Tuiketei et al. 2005).
Reducing the incidence of typhoid and limiting outbreaks
is now seen as a priority for the MOH (FMOH 2011).
Setting and methods
In August 2012, the MOH, with support from Australian
Aid, hosted a meeting of national and international
typhoid fever specialists in an effort to develop, prioritise
and implement a comprehensive control and prevention
strategy for typhoid in Fiji. This article summarises the
known epidemiology, clinical characteristics and microbi-
ological trends of typhoid and highlights corresponding
gaps in practice and policies relevant to the disease in
Fiji. This epidemiological evaluation was conducted using
available published data, MOH documents and informa-
tion from interviews with members of the local public
health, medical, and water and sanitation communities.
Data regarding all laboratory-confirmed S. typhi cases
spanning January 2008–August 2012 were provided by
the Fiji Centre for Communicable Disease Control, Mata-
ika House, Fiji MOH. Data were cleaned and imported
into STATA v11 (StataCorp, TX, USA), and descriptive
analyses on age, sex, ethnicity and geographic location
were performed. A summary and brief description of the
recommendations developed during the meeting are also
presented and discussed in the context of the realities of
disease control in Fiji.
The epidemiology of typhoid in Fiji
Some South Pacific islands have been known to experi-
ence high typhoid fever incidence rates and outbreaks.
For example, a prospective, population-based study con-
ducted in rural Papua New Guinea in the mid-1990’s
found an incidence of culture-positive typhoid fever of
817/100 000 population (Talme et al. 1994; Passey
1995). Additional available reports from the region
include outbreaks in Nauru in the Central Pacific and in
Western Samoa after cyclones Ofa and Val in 1990–93
(SDOH 1993; Olsen et al. 2001). Recent data from other
low- and middle-income countries in the region are lim-
ited (Olsen et al. 2001; Dunn et al. 2005).
Incidence and recent trends
Typhoid fever is endemic in Fiji, and there has been a
steep increase in reported cases over the last decade
(FMOH 2010a). Prior to 2005, the incidence of reported
culture-confirmed cases of typhoid was generally <5/
100 000 population (Dunn et al. 2005; Tuiketei et al.
2005). However, this figure increased to 33/100 000 in
2005 (Dunn et al. 2005) and climbed to 44, 40, 52 and
42/100 000 in 2008, 2009, 2010 and 2011, respectively
(Scobie et al. 2014). Explanations for this sudden
increase from 2005 may include better surveillance and
diagnostics, improved clinician awareness and/or an
actual increase in caseload (Dunn et al. 2005; Tuiketei
et al. 2005; FMOH 2010a; Jenkins 2010).
Available clinical and laboratory-confirmed surveillance
data suggest that Fiji experiences a peak of typhoid cases
between January and June annually, corresponding
approximately with the peak of the rainy season that
extends from November to April (WHO/FMOH/UNDP
2011; Scobie et al. 2014). The distribution of reported
cases of typhoid in Fiji varies dramatically geographically,
although it is generally considered a more substantial
problem in rural areas (FMOH 2010a). The main island
of Viti Levu is comprised of the Central and Western
Divisions and has several large coastal cities and a spar-
sely populated interior (Figure 1). The second largest
island (Vanua Levu) comprises the majority of the North-
ern Division and has historically reported both a higher
incidence and a higher absolute number of typhoid cases
than the other divisions (Dunn et al. 2005). In 2008, the
estimated incidence of reported culture-confirmed cases
per 100 000 population was 176, 22 and 19 in the
Northern, Western and Central divisions, respectively
(Scobie et al. 2014). It has been suggested anecdotally
that typhoid has been endemic for a considerable time on
Vanua Levu, yet is relatively new on Viti Levu (Jenkins
2010; Scobie et al. 2014) (Figure 1). However, disease
patterns are difficult to characterise accurately as major
gaps remain in typhoid surveillance.
Case description
Of the 1847 culture-confirmed typhoid cases reported
between January 2008 and July 2012, the median (range)
age was 25 (0–95) years (Figure 2a) and 1043 (57%)
were male, which is consistent with previous reports from
© 2014 The Authors. Tropical Medicine & International Health published by John Wiley & Sons Ltd. 1285
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Fiji (Dunn et al. 2005; Scobie et al. 2014). The highest
laboratory-confirmed incidence (average: 64/100 000
population) was among 15- to 29-year-olds (Figure 2b).
High incidence among young adults is similar to previous
reports from Fiji (Dunn et al. 2005; Scobie et al. 2014),
although contrasts with other regions endemic for
typhoid where incidence generally peaks among young
and school-aged children (Ochiai et al. 2008). However,
rigorous population-based studies of the age distribution
of typhoid fever suggest that the average age of typhoid
cases appears to fall as incidence rates increase; a peak of
cases among young adults is consistent with a medium
incidence setting (Crump et al. 2004). However, there
may also be age-related diagnosis and reporting biases
present as laboratory confirmation in young patients may
be hampered by a low blood culture volume (FMOH
2010a), differences in clinical presentation by age and the
notoriously challenging non-specific symptoms in this age
group (Bhutta 2006). This is further compounded by
inconsistent case definitions for paediatric typhoid, which
differ among hospitals in Fiji and make a combined
analysis of typhoid in children of little value.
The population of Fiji is composed of both indigenous
Fijians (57%, predominately Melanesian) and Fijians of
Indian ancestry (38%) who descend largely from Indian
contract labourers brought to the islands by the British in
the 19th century (FBOS 2007). Typhoid appears to affect
primarily indigenous Fijians, with >90% of all reported
cases occurring in this group (Dunn et al. 2005; FMOH
2010a; Singh 2010; Scobie et al. 2014). The reasons
behind the association with typhoid and ethnic group are
unclear. It is possible that cultural and behavioural prac-
tices may influence the transmission of typhoid in this set-
ting (Singh 2010). Alternatively, the 2007 census shows
Fijians of Indian ancestry are more likely than indigenous
Fijians to live in urban areas (57% vs. 44%, respectively)
(FBOS 2007), where the prevalence of typhoid is thought
to be lower (FMOH 2010a). Additionally, Fijians of
Indian ancestry may have different health-seeking behav-
iour and consequently may present to private general
practitioners before typhoid fever is suspected and/or able
to be cultured (Singh 2010). Although such private prac-
tices are required to report suspected cases of typhoid to
the MOH (fever ≥3 days with severe headache, abdomi-
nal pain, diarrhoea or constipation; recent travel; case
contact) (PHA 2013), compliance may be limited.
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Figure 1 Average annual laboratory-confirmed incidence of
S. Typhi cases per 100 000 population in Fiji by subdivision,
January 2008–August 2012. Incidence per 100 000 population is
indicated by colour, with darker colours reflecting higher inci-
dence. The capital of Fiji, Suva, is shown by the black star.
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Figure 2 Age distribution of laboratory-confirmed typhoid fever
cases in Fiji, 2008–2011. (a) Total number of reported cases by
age and sex, blue: male cases; red: female cases. (b) The age-
specific incidence per 100 000 population.
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Transmission
Epidemiologic research on the patterns and mechanisms
of typhoid transmission in Fiji has not been performed,
and no risk factors have been investigated or substanti-
ated. However, transmission studies have been per-
formed in other countries in the region, with
consumption of fish contaminated with sewage suggested
as the source of an outbreak in Nauru, for example (Ol-
sen et al. 2001). A hypothesis amongst some in the
Fijian public health community is that transmission of
S. typhi takes place largely through the consumption of
a popular drink known as kava or yaqona. Kava is
made by grinding the root of the plant Piper methysti-
cum and mixing it with water by hand. It has mild
anaesthetic and anxiolytic properties (Sarris et al. 2013),
and is consumed socially, mostly among men who
gather and share one bowl. Traditionally, indigenous
Fijian men are most likely to consume kava, but some-
times women and Fijians of Indian ancestry are invited
to share a bowl. Additional hypotheses of transmission
include poor personal hygiene and sanitation, particu-
larly in the context of large social gatherings with
shared food (Kreidl 2008; FMOH 2010a). Furthermore,
the Fijian population is known to have a high rate of
gallbladder abnormalities (Gill 2006). As gallbladder
disease is associated with becoming a chronic carrier of
typhoid after infection (Levine et al. 1982; Parry et al.
2002; Gonzalez-Escobedo et al. 2011), there is potential
for a high prevalence of carriers in the population who
could act as reservoirs for infection (Parry et al. 2002).
The true prevalence of chronic typhoid carriers in this
population is unknown.
Cyclone Tomas and the vaccination campaign of 2010
In March 2010, a category IV (winds of up to 251 km/h)
tropical cyclone (cyclone Tomas) hit Fiji, resulting in
substantial damage and disruption of water and sanita-
tion in the Northern Division including Vanua Levu and
Taveuni, the second and third largest islands, respectively
(Jenkins 2010). In response to the cyclone, the MOH ini-
tiated a vaccination campaign using Typhim Vi (polysac-
charide), targeting all residents over the age of 2 years in
areas impacted by the cyclone (Scobie et al. 2014). Two
months after the cyclone, a large typhoid fever outbreak
occurred in the central highlands of Viti Levu, the largest
island (which was largely unaffected by the cyclone),
with 29 culture-confirmed cases and an additional 250
suspected cases. Until this outbreak, typhoid had not
been previously reported in this area (Jenkins 2010).
Therefore, vaccine procured for the preventive
post-disaster response was used reactively in the outbreak
areas as well (Scobie et al. 2014). Scobie and colleagues
recently published an evaluation of this large-scale Vi-
polysaccharide vaccine intervention, the first of its kind
in a post-disaster setting in the Pacific (Scobie et al.
2014). Between June and December 2010, approximately
70 000 doses of vaccine were administered to all individ-
uals ≥2 years of age in various parts of the country; cov-
erage of the target population in regions of the
vaccination campaign ranged from 84% to over 100%
(due to discrepancies in population present and census
data) (Scobie et al. 2014). Approximately 7% of the
total Fijian population was vaccinated during this cam-
paign (Scobie et al. 2014). Further evaluation of the cam-
paign is ongoing.
Clinical characteristics & microbiological trends
Physicians in Fiji reported an increase in the number of
clinical typhoid fever cases among patients seen in clinics
from 2005 onward, lending credibility to an actual
increase in incidence of typhoid from that period (Dr
Shrish Acharya, Colonial War Memorial Hospital, per-
sonal communication). However, the clinical presentation
of typhoid is variable and overlaps with other febrile con-
ditions, making an accurate diagnosis difficult. Culture-
confirmed typhoid case fatality rates remain low in Fiji
(Tuiketei et al. 2005). Yet it is estimated that 60–90% of
typhoid patients do not get medical treatment or are trea-
ted as outpatients (Tuiketei et al. 2005; Kreidl 2008),
complicating generalisability of hospital-based fatality
rates.
The sale of antimicrobials is generally well controlled
in both hospitals and the private sector in Fiji. Chloram-
phenicol was the first-line antimicrobial for the treatment
of typhoid in Fiji until 2010 when the MOH recom-
mended ciprofloxacin as the treatment of choice for all
patients (except pregnant women) (FMOH 2010b).
Treatment with ciprofloxacin was implemented to reduce
the potential for long-term carriage and to shorten the
treatment course to improve patient adherence (FMOH
2010a). Although MOH guidelines state the optimal cip-
rofloxacin dose is 15 mg/kg with a maximum of 30 mg/
kg daily for 5 days (FMOH 2010b), complying with
World Health Organization (WHO) recommendations
(WHO 2003), the standard ciprofloxacin dosage for
adults at the main hospital in the capital Suva is 500 mg
twice daily. This dose is appropriate within the MOH
guidelines for patients weighing 33–66 kg. The average
weight of adult males and female Fijians, however, has
been shown to be greater than this (90 and 70 kg, respec-
tively) (Brian et al. 2011), suggesting that there may be a
© 2014 The Authors. Tropical Medicine & International Health published by John Wiley & Sons Ltd. 1287
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level of under-dosing in hospitalised patients, particularly
in adult males. Although side effects of increased dosing
of ciprofloxacin are possible, the minimum dose of
15 mg/kg for a 90-kg person is still within recommended
dosing strategies for conditions such as bone and skin
infections (FDA 2004).
Isolation of Salmonella is performed at three hospitals
in Fiji, all of which have trained microbiology staff with
automated microbial detection and antimicrobial suscep-
tibility testing capacity. The microbiology laboratories
aim to identify bloodstream infection in suspected
typhoid patients by inoculating blood in tryptone soya
broth and sodium polyethanol sulphonate, or to isolate
Salmonella from other sites by plating stool, rectal swabs,
urine or gallbladder aspirates directly onto MacConkey
and/or Xylose Lysine Deoxycholate (XLD) agar plates.
On observation of turbidity in blood cultures, they are
subcultured onto MacConkey and other media. Suspected
Salmonella from MacConkey and/or XLD agar plates are
distinguished from other Gram-negative bacteria using
the Microbact A&B system, a biochemical short-set (tri-
ple sugar iron) and lysine indole motility. Further identifi-
cation is performed by serogrouping; all suspected
invasive Salmonella are subjected to slide agglutination to
identify Group A (O2 – suspected S. Paratyphi A), Group
D (O9 – suspected S. typhi) and Vi positive (S. typhi)
Salmonella (Singh 2010). S. Paratyphi A is very rarely
identified in Fiji (Dunn et al. 2005).
Currently, resistance to antimicrobials in S. typhi is
uncommon in Fiji. From a report examining 441 cases of
S. typhi infection from 2000 to 2010 from the Central/
Eastern Division, none of the isolates were resistant to
any of the antimicrobials tested (including cephalosporins
and fluoroquinolones) (Singh 2010). This low prevalence
of antimicrobial resistance confirms previous findings
(Dunn et al. 2005) and suggests that the global epidemic
caused by S. typhi strains with reduced susceptibility to
fluoroquinolones has not, as yet, reached Fiji (Chau et al.
2007).
Current policy and practice gaps
Surveillance and reporting
The rapid identification of typhoid cases is critical for the
control and treatment efforts of the Fijian MOH. There
are currently two typhoid surveillance systems in Fiji: one
based on clinical reporting and the other based on cul-
ture-confirmed cases. The lack of any sensitive and spe-
cific clinical characteristics to distinguish among typhoid
fever, leptospirosis and dengue fever limits the reliability
of clinical diagnoses (WHO/FMOH/UNDP 2011).
Timeliness of reporting and high levels of incomplete
documentation are consistent issues affecting typhoid
reporting and surveillance in Fiji, making evaluation of
the dynamics of typhoid in this country difficult (Saun-
ders 2001; Dunn et al. 2005). An additional limitation is
the lack of reporting by private practitioners (Kreidl
2008). As outbreaks of typhoid continue to occur in Fiji,
in addition to ongoing endemic disease, upgrading the
surveillance system will be important to identify sources
of infection, prevent additional outbreaks and monitor
the epidemiology of typhoid to better inform policy
development (Koroivueta et al. 2010).
Water & sanitation infrastructure
Fiji and other Pacific island countries face many chal-
lenges in providing access to safe drinking water. These
challenges include the constant threat of natural disasters,
poor water supply infrastructure and highly variable
abundance of water resources (Dupont 1986; Sem &
Underhill 1992; Duncan 2011). According to the United
Nations Children’s Fund (UNICEF) and WHO, 97% of
urban Fijians have access to improved piped water com-
pared with 66% in rural areas (WHO/UNICEF 2012).
However, despite the existence of water quality standards
(FMOH 2006), urban water supplies are not generally
considered to be microbiologically safe due to lack of
enforcement (David Duncan, Applied Geoscience and
Technology Division of the Secretariat of the Pacific
Community [SOPAC], personal communication). A sec-
ondary and important threat is the frequent loss of posi-
tive pressure of the municipal supply pipeline, which
risks seepage of faecally contaminated material from the
local environment. Additionally, populations living in
rural areas are wholly reliant on untreated water, primar-
ily sourced from surface water such as rivers. In such
rural villages, there is limited maintenance of septic tanks
and other waste storage facilities, if such facilities are
present at all. Thus, the combination of poor sanitation
systems and continuously saturated soil creates an envi-
ronment where the potential for contamination of surface
and groundwater via leaking or improperly designed toi-
lets or waste storage facilities is considerable (David Dun-
can and Kamal Khatri, SOPAC, personal
communication).
Recommendations for the reduction of the disease
burden
In August 2012, the Fijian MOH hosted a meeting of
local and international partners with the aim of develop-
ing a holistic approach to typhoid control in Fiji. Overall,
1288 © 2014 The Authors. Tropical Medicine & International Health published by John Wiley & Sons Ltd.
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it was felt that typhoid in Fiji could be addressed effec-
tively due to the existence of a well-organised public
health and healthcare system, a lack of antimicrobial
resistance and controlled use of antimicrobials in the
community. The current lack of S. paratyphi A was also
seen as fortunate for controlling enteric fever as there is
no vaccine for this serovar. However, the threat of anti-
microbial resistance, either through importation or local
evolution, led experts to suggest a sense of urgency in
curbing the burden of typhoid in Fiji before the problem
escalates (Parry 2004). The specific recommendations of
the panel were split into two large categories: informa-
tion required and actions needed.
The primary information requirements centre on col-
lecting more data on the epidemiology of typhoid in the
community (Table 1). Defining potential risk factors for
disease through the use of rationally designed case–con
trol investigations was considered an important priority.
Further analysis of vaccine effectiveness after the 2010
campaign was suggested in addition to the ongoing
analyses (Scobie et al. 2014), using any available stored
records, case–control investigations and through prospec-
tive evaluation of incoming typhoid patients. Exploring
the viability of potential transmission pathways was also
thought to be of value. Assessing growth and survival
rates of S. typhi in the popular drink kava was encour-
aged, as even limited contamination of a kava bowl,
combined with reasonable survival rates, could serve as a
source of infection. Culturing bile aspirates from patients
undergoing cholecystectomy operations to estimate the
prevalence of S. typhi carriage in the community was also
recommended (Dongol et al. 2012). Additionally, a sero-
logical survey of a cross-section of the population using
both the Vi and Hd antigens was suggested to evaluate
the rates of exposure amongst various age and ethnic
groups. These measures were recommended to help
inform future control policy, specifically whether a
school-based vaccination strategy would be effective
given the intensity of transmission and associated age dis-
tribution of culture-confirmed typhoid cases.
Action-based recommendations (Table 2) included
standardising clinical case definitions for children and
optimising treatment regimens for adults such that the
recommended dose of ciprofloxacin is appropriate to the
Table 1 A summary of recommendations to address information needs developed by the expert panel for the reduction and control of
typhoid fever in Fiji
Information required
Area Recommendation Rationale
Design and implement case–control
study for risk factors
Attempt to identify important transmission
routes of typhoid in Fiji and, in particular,
determine likely causes for recent increase
in case numbers and disparate ethnic distribution
Allow targeted interventions against salient
risk factors or transmission routes
Design and implement case–control
and prospective epidemiological
analyses for further evaluation of
2010 vaccination campaign
Follow-up of any of the 70 000 individuals
who were vaccinated in 2010; estimating the
incidence in those who were not vaccinated
in 2010 (<2 years of age) and compare to
pre-campaign estimates to investigate evidence
of herd immunity
Guide future vaccine policy: estimate
effectiveness over time
Serological survey Perform prospective or retrospective survey to
quantify Vi and Hd antibody levels in various
demographic subpopulations to estimate rates
of exposure to S. typhi
Guide future vaccine policy: identify age
stratified infection rates to target
vaccination to appropriate age groups
Clinical audit of cases;
pharmacokinetic study
Compare clinical failure or relapse rates against
the weight and dosage of antimicrobial agent
prescribed, and perform a pharmacokinetic
study to identify an optimal dosage of
ciprofloxacin in this population
Guide treatment recommendations to reduce
relapse, treatment failure and gallbladder
carriage in the community
Microbiological studies Attempt to grow S. typhi in kava, a commonly
consumed drink and hypothesised transmission
route
Explore viability of this transmission route
to guide prevention strategies
Gallbladder bile culture analysis Culture bile aspirates from cholecystectomy
patients to estimate the prevalence of
asymptomatic chronic S. typhi carriage
Explore strategies for chronic carrier
detection and prevention of transmission if
carriage prevalence is high
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Fijian population. These were considered to be largely
straightforward and inexpensive tasks that would sub-
stantially improve case management. Encouragement of
proper hand hygiene for epidemiologically important
groups such as food and drink preparers was also
emphasised. Limiting the search for carriers to cholecys-
tectomy patients and point source outbreaks was sug-
gested to reduce the considerable workload of local
microbiological laboratories that are currently required to
perform stool surveys during patient contact tracing.
Stool culture is an insensitive method for detecting S. ty-
phi infection and carriage (Baker et al. 2010), and it was
recommended that the practice of screening contacts as
such be abandoned. Although it would be complicated by
high-vaccination coverage in some areas, the panel sug-
gested developing a serological method to screen contacts
for IgG to the Vi or Hd antigen (Lanata et al. 1983;
Chart et al. 2000).
For a more long-term solution, it was recommended
that drinking water storage and treatment at the house-
hold level, including the more reliable disinfection of
urban supplies, should be optimised if the case–control
investigations indicate such issues as risk factors. The
panel also suggested a review of current toilet designs to
reduce leakage into rain-sodden soil and to limit environ-
mental transmission of S. typhi. Finally, the panel recom-
mended developing a vaccination strategy dependent
upon the serologic evaluation of exposure and further
analysis of the previous vaccination campaign.
Conclusions
Typhoid appears to be a considerable problem in Fiji,
although basic epidemiological data are limited. How-
ever, the notable absence of antimicrobial resistance
within the S. typhi population and the relative isolation
of this island nation make typhoid management and con-
trol a real possibility in Fiji. The panel meeting hosted by
the Fijian MOH in August 2012 discussed the current sit-
uation in the country, shared relevant experiences in
typhoid control in both Fiji and other locations, con-
sulted with local partners and developed a comprehensive
Table 2 A summary of recommendations for action developed by the expert panel for the reduction and control of typhoid fever in
Fiji
Action needed
Area Recommendation Rationale
Case management
and documentation
Standardise the typhoid clinical case definition for children
across all hospitals, review blood culture guidelines to
obtain appropriate volumes of blood from patients; ensure
accurate collection of patient information such as residential
address and vaccination status
Enable the ability to compare surveillance
data across sites and draw reliable
conclusions from epidemiological
information of patients
Carrier detection Cease the current practice of stool culture for community
carrier identification and for contacts of typhoid patients;
consider developing a Vi-serology based screening method
for contacts
Stool culture is insensitive and eliminating
it from routine practice will save resources
Environment Work with local water and sanitation experts to optimise
village water supplies and storage and treatment of
household water and to upgrade toilet design to prevent
environmental leakage
Faulty, poorly designed and/or lack of
toilets may play an important role in
maintaining typhoid transmission in Fiji
Hygiene Develop a public information campaign to focus on
handwashing for epidemiologically important groups
such as food and drink preparers
Reduce the potential for point source
transmission due to infected individuals
and target resources efficiently
Vaccination Consider implementation of a typhoid vaccine programme;
additional analyses such as an economic evaluation and/or
modelling vaccination impact should also be considered
Ensure efficient use of limited resources for
vaccination by targeting appropriate
subpopulations (e.g. schoolchildren,
food handlers)
Long-term local
capacity building
Develop a group of local individuals trained in basic
epidemiology, microbiology and molecular biology
Form a hub of expertise to drive future
disease control efforts
Information management Streamline surveillance and laboratory data collection and
management to ensure that data is consistent, linked with
any relevant microbiology information and accessible to
members of the public health community
Effectively make use of the large amount
of data that is currently collected
by the MOH
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set of measures for the Fijian MOH to consider imple-
menting. A coordinated action plan, funding and support
are required to sustain the current momentum in combat-
ing typhoid, particularly with the potential threat of the
evolution or importation of antimicrobial-resistant
strains. Finally, due to broad similarities in culture, cli-
mate and geography, a successful control programme in
Fiji could potentially be used as a model for typhoid con-
trol in the Pacific region as a whole.
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